RAD BioMed Accelerator

About The Fund

RAD BioMed Accelerator is a venture capital firm based in Tel Aviv, Israel, that specializes in early-stage investments within the biotechnology and medical devices sectors. They focus on equity investments in venture, seed, Series A, and Series B rounds, providing funding and strategic support to innovative startups. RAD BioMed is committed to fostering growth in pioneering companies that are focused on cutting-edge biomedical technologies and services. By leveraging industry expertise and a deep understanding of the biotech landscape, they aim to propel advancements in medical care and patient outcomes. Their investment portfolio spans a diverse array of biomedical fields, including novel drug development, medical diagnostics, and advanced therapies. Some key examples from their portfolio include Moebius Medical, a developer of osteoarthritis pain relief treatments; FEMSelect, which specializes in solutions for gynecological disorders; Zsquare, offering revolutionary single-use endoscopes; and RadiAction Medical, which is innovating in radiation shielding solutions. Additionally, RAD BioMed supports SynVaccine, a company working on synthetic biology to create new cancer immunotherapies and vaccines for infectious diseases, utilizing exclusive technologies from Tel Aviv University and the Weizmann Institute. These technologies facilitate the design and validation of synthetic viruses through advanced computational methodologies and DNA editing, streamlining the development of vital healthcare products. With their comprehensive specialization and a strategic location in the hub of Israeli innovation, RAD BioMed Accelerator is at the forefront of propelling disruptive healthcare solutions to market.